Skip to Content

Gammagard Liquid FDA Alerts

The FDA Alerts below may be specifically about Gammagard Liquid or relate to a group or class of drugs which include Gammagard Liquid.

MedWatch Safety Alerts are distributed by the FDA and published by Following is a list of possible medication recalls, market withdrawals, alerts and warnings.

Recent FDA Alerts for Gammagard Liquid

GammaGard Liquid, Immune Globulin Intravenous (Human)

[Posted 06/04/2010]

ISSUE: Baxter BioScience and FDA notified healthcare professionals of a market withdrawal being conducted as a precautionary measure due to an increased number of adverse event reports of allergic reactions associated with two lots of the product.

BACKGROUND: GammaGard Liquid is indicated for the treatment of primary immunodeficiency disorders associated with defects in humoral immunity.

RECOMMENDATION: Customers are asked to contact Baxter BioScience for Urgent Market Withdrawal instructions. See the Market Withdrawal Notice for information on affected lots.

[06/03/2010 - Market Withdrawal Notice - FDA]


More Gammagard Liquid Resources